Tirzepatide
AppetiteWeight
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied extensively for glycemic control, appetite signaling, and weight management.
What does it do?
- Lowers appetite so meals feel like enough sooner
- Cuts snacking and food noise
How does it work?
- Activates both GIP and GLP-1 receptors
- GLP-1 reduces hunger and slows digestion
What to expect?
- Food noise drops and a normal plate starts to feel like enough
- Snacking loses its pull and you forget about extra bites more easily
How it's typically administered
- Sub-Q injectionSubcutaneous injectiononce weekly; commonly delivered with a pre-filled pen
How it's typically dosed
- Most common dose2.5–15 mg
- FrequencyOnce weekly
- Cycle durationTitrated every 4 weeks
